[HTML][HTML] Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
PB Roy, VN Tejani, SS Dhillon, N Damarlapally… - Cureus, 2023 - ncbi.nlm.nih.gov
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
[PDF][PDF] Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
PB Roy, VN Tejani, SS Dhillon, N Damarlapally… - Cureus, 2023 - cureus.com
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
V Tejani, S Dhillon, N Damarlapally, T Winson… - Cureus, 2023 - europepmc.org
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
[PDF][PDF] Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
PB Roy, VN Tejani, SS Dhillon, N Damarlapally… - 2023 - assets.cureus.com
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
RP Basu, VN Tejani, SS Dhillon, D Nanush… - Cureus, 2023 - search.proquest.com
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
PB Roy, VN Tejani, SS Dhillon, N Damarlapally… - Cureus, 2023 - pubmed.ncbi.nlm.nih.gov
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
[PDF][PDF] Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
PB Roy, VN Tejani, SS Dhillon, N Damarlapally… - assets.cureus.com
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
Efficacy and Safety of Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review.
VN Tejani, SS Dhillon, N Damarlapally, T Winson… - Cureus, 2023 - europepmc.org
In recent times, novel oral anticoagulants (NOACs)/direct oral anticoagulants (DOACs) have
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …
emerged as an alternative to the traditionally used Vitamin K oral antagonists (VKA) like …